Related Experiment Video
Updated: Jun 27, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Mediating Effects of Immunophenotypes on the Causal Relationship of Gut Microbiota and Their Metabolic Pathways With
Minlong Wang1, Yongjiu Meng1, Qinrong Shen1
1Department of Orthopedics, Shaoxing Hospital of Traditional Chinese Medicine, Shaoxing TCM Hospital Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Background:
This study examined the potential causal relationship between gut microbiota and osteonecrosis and analyzed the mediating effects of immunophenotypes to establish evidence-based causal associations.
Methods:
Bayesian weighted Mendelian randomization and the inverse-variance weighted method were used to evaluate the causal relationships between osteonecrosis and 412 gut microbial species and their metabolic pathways, as well as between osteonecrosis and 731 immune cell signatures. Mediation analysis was conducted to assess the role of immune cells in mediating the relationship between gut microbiota and osteonecrosis.
Results:
A total of 16 gut microbial species and their metabolic pathways and 23 immunophenotypes were identified as causal factors in susceptibility to osteonecrosis (p < 0.05). The superpathway of sulfate assimilation and cysteine biosynthesis of the gut microbiota demonstrated a protective effect against osteonecrosis. The absolute count of CD33- HLA DR + Myeloid cell exhibited a mediation effect of 4.15%, while T cell %lymphocyte demonstrated a mediation effect of 12.16% in this protective mechanism.
Conclusion:
The study findings highlighted the role of the superpathway of sulfate assimilation and cysteine biosynthesis of the gut microbiota in exerting a protective effect against osteonecrosis. This protective effect is substantially mediated by a decrease in the absolute count of CD33- HLA DR + Myeloid cell and an increase in T cell % lymphocyte.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
The Oral Microbiota
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics

